Wai Yuen Tong Medicine Holdings First Half 2025 Earnings: EPS: HK$0.021 (vs HK$0.004 loss in 1H 2024)

Wai Yuen Tong Medicine Holdings (HKG:897) First Half 2025 Results

Key Financial Results

• Revenue: HK$346.8m (down 5.8% from 1H 2024).
• Net income: HK$23.7m (up from HK$5.05m loss in 1H 2024).
• Profit margin: 6.8% (up from net loss in 1H 2024).
• EPS: HK$0.021 (up from HK$0.004 loss in 1H 2024).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Wai Yuen Tong Medicine Holdings shares are up 15% from a week ago.

Risk Analysis

Before you take the next step you should know about the 4 warning signs for Wai Yuen Tong Medicine Holdings that we have uncovered.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.